Newborn screening for hemoglobinopathies in Colorado. The first 10 years

Area of Science:

• Medical Genetics
• Pediatrics
• Public Health

Background:

• Newborn screening for hemoglobinopathies, including sickle cell disease, is crucial for early diagnosis and intervention.
• Electrophoresis methods have been used for hemoglobinopathy detection in newborns since 1979.
• The Colorado newborn screening program aimed to identify infants with these genetic blood disorders.

Purpose of the Study:

• To review the effectiveness and outcomes of the Colorado newborn screening program for hemoglobinopathies.
• To assess the accuracy and limitations of the established screening methods.
• To evaluate the impact of screening on identified cases of sickle cell disease.

Main Methods:

• Analysis of screening data for 528,711 infants born in Colorado between 1979 and 1988.
• Utilized cellulose acetate and citrate agar electrophoresis on dried capillary blood spots.
• Follow-up data on infants diagnosed with sickle cell diseases through September 1989.

Main Results:

• Identified 47 infants with sickle cell diseases and 27 with other hemoglobin diseases.
• The screening program detected no mortality among the 47 infants with sickle cell diseases.
• Initial screening missed 4 cases of sickle cell anemia, but 3 were caught on routine retesting for sickle cell trait.

Conclusions:

• Newborn screening for hemoglobinopathies in Colorado has demonstrated significant value in identifying affected infants.
• The existing screening methods showed limitations, missing some cases of sickle cell anemia.
• Enhancing the sensitivity of screening tests is recommended to improve program effectiveness and early detection rates.